IL-17 is involved in bone resorption in mouse periapical lesions

Microbiology and Immunology

Volumn 53, Issue 5, 2009, Pages 287-294

  Oseko, Fumishige ^a   Yamamoto, Toshiro ^a   Akamatsu, Yuki ^a   Kanamura, Narisato ^a   Iwakura, Yoichiro ^b   Imanishi, Jiro ^a   Kita, Masakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Interferon; Interleukin 17; Micro computed tomography; Periapical lesion

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOLAR TOOTH; MOUSE; NONHUMAN; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THREE DIMENSIONAL IMAGING; TOOTH PERIAPICAL DISEASE; WILD TYPE; ANIMAL; BACTEROIDACEAE INFECTION; C57BL MOUSE; COMPUTER ASSISTED TOMOGRAPHY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MICROBIOLOGY; MOUSE MUTANT; PATHOPHYSIOLOGY; RADIOGRAPHY;

BACTERIA (MICROORGANISMS); MUS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA;

ANIMALS; BACTEROIDACEAE INFECTIONS; BONE RESORPTION; FEMALE; GENE EXPRESSION; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; PERIAPICAL DISEASES; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66849115049     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2009.00123.x     Document Type: Article

References (48)

1. Balto K., Sasaki H., Stashenko P. (2001) Interleukin-6 deficiency increase inflamatory bone destruction. Infect Immun 69: 744-50.
2. Fouad A. (1997) IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice. J Dent Res 76: 1548-54.
3. Huang G.T., Do M., Wingard M., Park J.S., Chugal N. (2001) Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92: 83-8.
4. Kawashima N., Stashenko P. (1999) Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 44: 55-66.
5. Sasaki H., Hou L., Belani A., Wang C.Y., Uchiyama T., Müller R., Stashenko P. (2000) IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 165: 3626-30.
6. Stashenko P., Teles R., D'Souza R. (1998) Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 9: 498-521.
7. Sasaki H., Balto K., Kawashima N., Eastcott J., Hoshino K., Akira S., Stashenko P. (2004) Gamma interferon (IFN-gamma) and IFN-gamma-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo. Clin Diagn Lab Immunol 11: 106-10.
8. Van Benzooijen R.L., Papaoulos S.E., Lowik C.W. (2001) Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? Bone 28: 378-86.
9. Vernal R., Dutan N., Chaparro A., Puente J., Valenzuela M.A., Gamonal J. (2005) Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 32: 383-9.
10. Oda T., Yoshie H., Yamazaki K. (2003) Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol 18: 30-36.
11. Takahashi K., Azuma T., Motohira H., Kinane D.F., KItetsu S. (2005) The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 32: 369-74.
12. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-87.
13. Hirakimoto A., Ohnishi S., Maeda H., Kishi T., Shiota T., Tamura T., Ukita M., Fujita S., Kamegawa M. (2004) Progress of microfocus X-ray systems for fluoroscopic and computed tomography. Spectrochimica Acta Part B: Atomic Spectroscopy 59: 1101-6.
14. Nango Y., Takeuchi K. (1997) Three-dimensional image processing. Kinnzoku 67: 653-63.
15. Nango Y. (1988) Three dimensional model reconstruction from serial section images using personal computer system. Saibou 20: 314-17.
16. Duran E.M., Shapshak P., Worley J., Minagar A., Ziegler F., Haliko S., Moleon-Borodowsky I., Haslett P.A.J. (2005) Presenilin-1 detection in brain neurons and FOXP3 in peripheral blood mononuclear cells: normalizer gene selection for real time reverse transcriptase pcr using the deltadeltaCt method. Frontiers in Bioscience 10: 2955-65.
17. Stechow D.V., Balto K., Stashenko P., Müller R. (2003) Three-dimensional quantitation of periradicular bone destruction by micro-computed tomography. J Endod 29: 252-6.
18. Balto K., Müller R., Carrington D.C., Dobeck J., Stashenko P. (2000) Quantification of periapical bone destruction in mice by micro-computed tomography. J Dent Res 79: 35-40.
19. Nielsen R.B., Alyassin A.M., Peters D.D., Carnes D.L., Lancaster J. (1995) Microcomputed tomography: an advanced system for detailed endodontic research. J Endod 21: 561-8.
20. Peters O.A., Laib A., Rüegsegger P., Barbakow F. (2000) Three-dimensional analysis of root canal geometry by high-resolution computed tomography. J Dent Res 79: 1405-9.
21. Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., Nakanishi K. (1998) Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 10: 259-64.
22. Wu C.Y., Demeure C., Kiniwa M., Gately M., Delespesse G. (1993) IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J Immunol 151: 1938-49.
23. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., Ikeda M., Kurimoto M. (1997) IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158: 1541-50.
24. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.A., Wolf S.F., Young D., Clark S.C., Trinchieri G. (1991) Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173: 869-79.
25. Boraschi D., Censini S., Tagliabue A. (1984) Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol 133: 764-8.
26. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. (1983) Identification of interferon- g as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670-89.
27. Pellat C., Henry Y., Drapier J.C. (1990) IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem Biophys Res Commun 166: 119-25.
28. Horwood N.J., Elliott J., Martin T.J., Gillespie M.T. (2001) IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166: 4915-21.
29. Horwood N.J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., Dunn A.R., Martin T., Gillespie M.T. (1998) Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Investig 101: 595-603.
30. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., Takaoka A., Yokochi T., Oda H., Tanaka K., Nakamura K., Taniguchi T. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-5.
31. Udagawa N., Horwood N.J., Elliott J., Mackay A., Owens J., Okamura H., Kurimoto M., Chambers T.J., Martin T.J., Gillespie M.T. (1997) Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185: 1005-12.
32. Yamada N., Niwa S., Tsujimura T., Iwasaki T., Sugihara A., Futani H., Hayashi S., Okamura H., Akedo H., Terada N. (2002) Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 30: 901-8.
33. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-57.
34. Romagnani S. (1991) Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res 21: 152-8.
35. Aarvak T., Chabud M., Miossec P., Natvig J.B. (1999) IL-17 is produced by some pro-inflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162: 1246-51.
36. Seymour G.J., Gemmell E. (2001) Cytokines in periodontal disease: where to from here? Acta Odontol Scand 59: 167-73.
37. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., Miossec P. (1999) Human interleukin-17: A T cell-derived pro-inflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42: 963-70.
38. Chabaud M., Fossiez F., Taupin J.L., Miossec P. (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161: 409-14.
39. Matusevicius D., Kivisall P., He N., Kostulas N., Ozenci V., Fredrikson S., Link H. (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5: 101-4.
40. Teunissen M.B., Koomen C.W., de Waal Malefyt R., Wierenga E.A., Bos J.D. (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of pro-inflammatory cytokine production by human keratinocytes. J Invest Dermatol. 111: 645-9.
41. Jovanovic D.V., Di Battieta J.A., Martel-Pelletier J., Jolicoeur F.C., He Y., Zhang M., Mineau F., Pelletier J.P. (1998) IL-17 stimulates the production and expression of pro-inflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513-21.
42. Chabaud M., Garnero P., Dayer J.M., Guerne P.A., Fossiez F., Miossec P. (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12: 1092-9.
43. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J.J., Garrone P., Garcia E., Saeland S., Blanchard D. Gaillard C., Das Mahapatra B., Rouvier E., Golstein P., Banchereau J., Lebecque S. (1996) T cell interleukin-17 induces stromal cells to produce pro-inflammatory and hematopoietic cytokines. J Exp Med 183: 2593-603.
44. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., Takayanagi H. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 12: 2673-82.
45. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin J., Suda T. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 1345-52.
46. Van Benzooijen R.L., Farih-Sips H.C., Papaoulos S.E., Lowik C.W. (1999) Interleukin-17: A new bone acting cytokine in vitro. J Bone Miner Res 14: 1513-21.
47. Yu J.J., Ruddy M.J., Wong G.C., Sfintescu C., Baker P.J., Smith J.B., Evans R.T., Gaffen S.L. (2007) An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-802.
48. Yu J.J., Ruddy M.J., Conti H.R., Boonanantanasarn K., Gaffen S.L. (2008) The Interleukin-17 Receptor Plays a Gender-Dependent Role in Host Protection against Porphyromonas gingivalis-Induced Periodontal Bone Loss. Infection and Immunity 76: 4206-13.